RAPAMUNE*30CPR RIV 1MG ( DrugBank: - )

1 disease

ID	Disease name (Link within this page)	Number of trials
67	Polycystic kidney disease	1

67. Polycystic kidney disease

Clinical trials : 216 / Drugs : 219 - (DrugBank : 50) / Drug target genes : 39 - Drug target pathways : 151

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-003427-37-IT (EUCTR)	05/02/2007	27/12/2006	Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and ...	Sirolimus treatment in patients with autosomal dominant polycystic kidney disease renal efficacy and ...	Autosomal-Dominant Polycystic Kidney Disease ADPKD MedDRA version: 9.1;Level: LLT;Classification cod ...	Trade Name: RAPAMUNE30CPR RIV 1MG INN or Proposed INN: Sirolimus Trade Name: RAPAMUNE30CPR RIV 2MG IN ...	IST. DI RICERCHE FARMACOLOG. M. NEGRI	NULL	Not Recruiting			Female: yes Male: yes	16	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Italy

First Previous1Next Last